4.2 Review

Neuropsychology 3.0: Evidence-Based Science and Practice

出版社

CAMBRIDGE UNIV PRESS
DOI: 10.1017/S1355617710001396

关键词

Neuropsychology; Genomics; Psychological theory; Psychological tests; Information science; Brain

资金

  1. Consortium for Neuropsychiatric Phenomics (NIH Roadmap for Medical Research) [UL1-DE019580, RL1LM009833]
  2. Cognitive Atlas project [R01MH082795]
  3. Michael E. Tennenbaum Family Center for the Biology of Creativity
  4. Roche
  5. CHDI
  6. Johnson Johnson
  7. Pfizer
  8. Cypress Pharmaceutical
  9. Dainippon Sumitomo
  10. NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024911] Funding Source: NIH RePORTER
  11. NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [UL1DE019580] Funding Source: NIH RePORTER
  12. NATIONAL INSTITUTE OF MENTAL HEALTH [PL1MH083271, R01MH082795] Funding Source: NIH RePORTER
  13. NATIONAL LIBRARY OF MEDICINE [RL1LM009833] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Neuropsychology is poised for transformations of its concepts and methods, leveraging advances in neuroimaging, the human genome project, psychometric theory, and information technologies. It is argued that a paradigm shift toward evidence-based science and practice can be enabled by innovations, including (1) formal definition of neuropsychological concepts and tasks in cognitive ontologies; (2) creation of collaborative neuropsychological knowledgebases; and (3) design of Web-based assessment methods that permit free development, large-sample implementation, and dynamic refinement of neuropsychological tests and the constructs these aim to assess. This article considers these opportunities, highlights selected obstacles, and offers suggestions for stepwise progress toward these goals. (JINS, 2011, 17, 7-13)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据